1-19 of 19
Steven Grant, MD
Close
Sort by
Articles

Non-Hodgkin Lymphoma: Is 1 Plus 1 Greater Than 2?

Steven Grant, MD
Journal: The Hematologist
The Hematologist (2011) 8 (6)
https://doi.org/10.1182/hem.V8.6.1203
Published: 2011
Articles

CML Stem Cells: No Longer Addicted

Steven Grant, MD
Journal: The Hematologist
The Hematologist (2011) 8 (4)
https://doi.org/10.1182/hem.V8.4.1257
Published: 2011
Articles

Non-Linear Evolutionary History of All Stem Cells

Steven Grant, MD
Journal: The Hematologist
The Hematologist (2011) 8 (3)
https://doi.org/10.1182/hem.V8.3.1275
Published: 2011
Articles

A Role for TET2 Dysregulation in Myeloid Malignancies

Steven Grant, MD
Journal: The Hematologist
The Hematologist (2011) 8 (2)
https://doi.org/10.1182/hem.V8.2.6305
Published: 2011
Articles

Targeting Methylation in Mantle Cell Lymphoma

Steven Grant, MD
Journal: The Hematologist
The Hematologist (2011) 8 (1)
https://doi.org/10.1182/hem.V8.1.6319
Published: 2011
Articles

HDAC Inhibitors to the Rescue

Steven Grant, MD
Journal: The Hematologist
The Hematologist (2010) 7 (6)
https://doi.org/10.1182/hem.V7.6.6252
Published: 2010
Articles

Attacking the Root of the Problem in CML

Steven Grant, MD
Journal: The Hematologist
The Hematologist (2010) 7 (3)
https://doi.org/10.1182/hem.V7.3.6241
Published: 2010
Articles

Setting Sights on a Bad Actor

Steven Grant, MD
Journal: The Hematologist
The Hematologist (2010) 7 (2)
https://doi.org/10.1182/hem.V7.2.6275
Published: 2010
Articles

Targeting the Resistance in CML

Steven Grant, MD
Journal: The Hematologist
The Hematologist (2010) 7 (1)
https://doi.org/10.1182/hem.V7.1.6276
Published: 2010
Articles

Proteasome Inhibitors Do the Unexpected

Steven Grant, MD
Journal: The Hematologist
The Hematologist (2009) 6 (6)
https://doi.org/10.1182/hem.V6.6.6190
Published: 2009
Articles

Molecular Profiling in Lymphoma Comes of Age

Steven Grant, MD
Journal: The Hematologist
The Hematologist (2009) 6 (5)
https://doi.org/10.1182/hem.V6.5.6182
Published: 2009
Articles

Linking HDAC and Proteasome Inhibition

Steven Grant, MD
Journal: The Hematologist
The Hematologist (2009) 6 (4)
https://doi.org/10.1182/hem.V6.4.6179
Published: 2009
Articles

Targeted Therapy: How Much and For How Long?

Steven Grant, MD
Journal: The Hematologist
The Hematologist (2009) 6 (3)
https://doi.org/10.1182/hem.V6.3.6196
Published: 2009
Articles

Targeting the Lipid Rheostat in Leukemia

Steven Grant, MD
Journal: The Hematologist
The Hematologist (2009) 6 (1)
https://doi.org/10.1182/hem.V6.1.6197
Published: 2009
Articles

Profiling AML Stem Cell Active Agents

Steven Grant, MD
Journal: The Hematologist
The Hematologist (2008) 5 (6)
https://doi.org/10.1182/hem.V5.6.6130
Published: 2008
Articles

Targeting NF-κB in CLL

Steven Grant, MD
Journal: The Hematologist
The Hematologist (2008) 5 (4)
https://doi.org/10.1182/hem.V5.4.6136
Published: 2008
Articles

NF-κB Profiling in Multiple Myeloma

Steven Grant, MD
Journal: The Hematologist
The Hematologist (2008) 5 (1)
https://doi.org/10.1182/hem.V5.1.6123
Published: 2008
Articles

Pharmacologic Recapitulation of the Cell Death Program

Steven Grant, MD
Journal: The Hematologist
The Hematologist (2007) 4 (4)
https://doi.org/10.1182/hem.V4.4.6065
Published: 2007
Articles

Susceptibility to Oxidative Stress - A Leukemic Cell’s Achilles’ Heel?

Steven Grant, MD
Journal: The Hematologist
The Hematologist (2007) 4 (1)
https://doi.org/10.1182/hem.V4.1.6077
Published: 2007